Published: 20 March 2020
Author(s): Amihai Rottenstreich, Tali Mishael, Sorina Grisaru Granovsky, Benjamin Koslowsky, Hagai Schweistein, Guila Abitbol, Eran Goldin, Ariella Bar-Gil Shitrit
Issue: July 2020
Section: Original article

Inflammatory bowel disease (IBD) is frequently diagnosed among reproductive-aged women, with 25% of women conceiving after diagnosis [1]. Associations of IBD with pregnancy outcomes have been extensively reported [2–6]. It has been well established, that achieving disease remission prior to conception is important to improve maternal and perinatal outcomes [4–6]. In addition, disease flares throughout gestation are not uncommon, occurring in approximately a third of women [4–6], and have been shown to increase the rate of adverse outcomes including fetal loss, preterm birth and the delivery of a small-for-gestational-age infant [1,7,8].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.